RVVTF REVIVE THERAPEUTICS LTD: institutional ownership and insider trading
1 funds reported holding $85 of REVIVE THERAPEUTICS LTD in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 1 funds selling out.
1 funds reported holding $85 of REVIVE THERAPEUTICS LTD in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 1 funds selling out.